CYCLIC TRYPSIN INHIBITOR
OrganismNot specified
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 1–14 | Not recorded | No other associated polymer | SOLUTION NMR NMR measurement conditions:pH 4.5;273 K;Ionic strength (raw mmCIF value) 20mM;Pressure ambient NMR measurement conditions:pH 4.5;313 K;Ionic strength (raw mmCIF value) 20mM;Pressure ambient NMR sample composition:1mM 14/1-lSFTI-1 | 20mM sodium phosphate, pH4.5, 20% trifluoroethanol, 10%D2O NMR sample composition:1mM 14/1-lSFTI-1 | 20mM sodium phosphate, pH4.5, 10%D2O NMR sample composition:1mM 14/1-lSFTI-1 | 20mM sodium phosphate, pH4.5, 20% trifluoroethanol, 80%D2O | Resolution not provided |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1JBN | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1JBL Solution structure of SFTI-1, A cyclic trypsin inhibitor from sunflower seeds Deposited 2001-06-05 | Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–14(14 aa)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 4.5;273 K;Ionic strength (raw mmCIF value) 20mM;Pressure ambient
NMR measurement conditions
pH 4.5;313 K;Ionic strength (raw mmCIF value) 20mM;Pressure ambient
NMR sample composition
1mM SFTI-1 | 20mM sodium phosphate,pH 4.5,
20% trifluoroethanol,
10% D2O
NMR sample composition
1mM SFTI-1 | 20mM sodium phosphate,pH 4.5,
10% D2O
NMR sample composition
1mM SFTI-1 | 20mM sodium phosphate,pH 4.5,
20% trifluoroethanol,
100% D2O
|
Resolution not provided |
| 1SFI High resolution structure of a potent, cyclic protease inhibitor from sunflower seeds Deposited 1998-12-16 | Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain I
1–14(14 aa)
|
Not recorded | SO4 SULFATE ION × 3 CA CALCIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;pH 8.0
|
Resolution 1.65 Å R-free 0.204 |
| 1T9E NMR solution structure of a disulfide analogue of the cyclic sunflower trypsin inhibitor SFTI-1 Deposited 2004-05-16 | Different construct Different mutation/modification Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
40–53(14 aa)
|
Mutation:C3(ABA), C11(ABA) Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 4.5;290 K;Pressure ambient
NMR sample composition
10 mM peptide in 0.5 ml solvent | 90% H2O/10% D2O
NMR sample composition
10 mM peptide in 0.5 ml solvent | 100% D2O
|
Resolution not provided |
| 2AB9 Discovery, structural determination and processing of the precursor protein that produces the cyclic trypsin inhibitor SFTI-1 Deposited 2005-07-15 | Different construct Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
26–56(31 aa)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 4;298 K;Ionic strength (raw mmCIF value) NA;Pressure ambient
NMR sample composition
approx 1mM pro-SFTI-1, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
approx 1mM pro-SFTI-1, 100% D2O | 100% D2O
|
Resolution not provided |
| 3P8F Crystal Structure of MT-SP1 in complex with SFTI-1 Deposited 2010-10-13 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain I
40–53(14 aa)
Fragment:UNP RESIDUES 40-53
|
Not recorded | GSH Glutathione × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;297 K;0.1M Tris.HCl pH 8.0, 22% PEG 8K, 20mM CaCl2, vapor diffusion, hanging drop, temperature 297K
|
Resolution 2.00 Å R-free 0.245 |
| 4ABI Co-complex structure of bovine trypsin with a modified Bowman-Birk inhibitor (PtA)SFTI-1(1,14), that was 1,4-disubstituted with a 1,2,3- trizol to mimic a trans amide bond Deposited 2011-12-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
40–53(14 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | CA CALCIUM ION × 1 DMF DIMETHYLFORMAMIDE × 3 GOL GLYCEROL × 7 SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
1.85 M (NH4)2SO4,50 MM TRIS PH 8.5 WITH 60 MG/ML TRYPSIN (SIGMA T1246) IN 0.3 M (NH4)2SO4, 6 MM CACL2, 0.1 M TRIS PH 8.15, 60 MM BENZAMIDINE. TO 10 UL PROTEIN SOL 0.5 UL DIMETHYLFORMAMID WAS ADDED PRIOR CRYSTAL SET UP. CRYSTALS WERE SOAKED WITH PTA-SFTI (ADDED IN LYOPHYLIZED FORM TO THE CRYSTALLIZATION DROP AFTER 2 WEEKS CRYSTAL GROWTH). TOTAL SOAKING TIME 8 DAYS.
|
Resolution 1.55 Å R-free 0.220 |
| 4ABJ Co-complex structure of bovine trypsin with a modified Bowman-Birk inhibitor (IcA)SFTI-1(1,14), that was 1,5-disubstituted with 1,2,3- trizol to mimic a cis amide bond Deposited 2011-12-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
40–53(14 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | CA CALCIUM ION × 1 DMF DIMETHYLFORMAMIDE × 1 GOL GLYCEROL × 4 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
2.0 M (NH4)2SO4,50 MM TRIS PH 8.5 WITH 30 MG/ML TRYPSIN (SIDMA T1246) IN 0.3 M (NH4)2SO4, 6 MM CACL2, 0.1 M TRIS PH 8.15, 60 MM BENZAMIDINE) TO 10 UL PROTEIN SOL 0.5 UL DIMETHYLFORMAMID WAS ADDED PRIOR CRYSTAL SET UP CRYSTALS WERE SOAKED WITH ICA-SFTI (ADDED IN LYOPHYLIZED FORM TO THE CRYSTALLIZATION DROP AFTER 2 WEEKS). TOTAL SOAKING TIME 8 DAYS.
|
Resolution 1.45 Å R-free 0.204 |
| 4HGC Crystal structure of bovine trypsin complexed with sfti-1 analog containing a peptoid residue at position p1 Deposited 2012-10-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain I
40–53(14 aa)
Fragment:unp residues 40-53
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | CA CALCIUM ION × 1 GOL GLYCEROL × 5 SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;292 K;2.3 M ammonium sulphate, 1 mM benzamidine and 0.1 M Mes, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 1.29 Å R-free 0.157 |
| 4K1E Atomic resolution crystal structures of Kallikrein-Related Peptidase 4 complexed with a modified SFTI inhibitor FCQR Deposited 2013-04-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
40–53(14 aa)
|
Mutation:modified FCQR | MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1 LI LITHIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;0.1M lithium sulfate, 0.1M sodium acetate, 30% PEG 8000 , pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.30 Å R-free 0.170 |
| 4K8Y Atomic resolution crystal structures of Kallikrein-Related Peptidase 4 complexed with Sunflower Trypsin Inhibitor (SFTI-1) Deposited 2013-04-19 | Different construct Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
40–53(14 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.8;293 K;0.2M Lithium Sulfate, 0.1M Sodium Acetate, 20%(w/v) PEG 8000, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.00 Å R-free 0.170 |
| 4KEL Atomic resolution crystal structure of Kallikrein-Related Peptidase 4 complexed with a modified SFTI inhibitor FCQR(N) Deposited 2013-04-25 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
40–53(14 aa)
|
Mutation:modified FCQR(N) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;0.1M lithium sulfate, 0.1M sodium acetate, 30% PEG 8000, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.15 Å R-free 0.163 |
| 4XOJ Structure of bovine trypsin in complex with analogues of sunflower inhibitor 1 (SFTI-1) Deposited 2015-01-16 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
40–52(13 aa)
Fragment:UNP residues 40-52
|
Not recorded | SO4 SULFATE ION × 1 EDO 1,2-ETHANEDIOL × 7 CA CALCIUM ION × 1 NA SODIUM ION × 3 NH4 AMMONIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;sodium acetate trihydrate, PEG 8000, ammonium sulphate
|
Resolution 0.91 Å R-free 0.114 |
| 6D3X Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma Deposited 2018-04-17 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
40–53(14 aa)
Fragment:UNP residues 40-53
|
Mutation:T4Y, I7K | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;21% PEG4000, 0.1 M magnesium chloride, 0.1 M sodium citrate
|
Resolution 1.80 Å R-free 0.216 |
| 6D3X Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma Deposited 2018-04-17 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
40–53(14 aa)
Fragment:UNP residues 40-53
|
Mutation:T4Y, I7K | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;21% PEG4000, 0.1 M magnesium chloride, 0.1 M sodium citrate
|
Resolution 1.80 Å R-free 0.216 |
| 6D3Y Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma Deposited 2018-04-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
40–53(14 aa)
Fragment:UNP residues 40-53
|
Mutation:I7R | SO4 SULFATE ION × 1 GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;0.1 M 2-ethanesulfonic acid, 0.15 M ammonium sulfate, 13% PEG4000
|
Resolution 1.32 Å R-free 0.213 |
| 6D3Z Protease SFTI complex Deposited 2018-04-17 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
40–53(14 aa)
Fragment:UNP residues 40-53
|
Mutation:T4Y, I7R, D14N | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;0.1 M sodium acetate, 1 M sodium formate
|
Resolution 2.00 Å R-free 0.203 |
| 6D40 Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma Deposited 2018-04-17 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
40–53(14 aa)
Fragment:UNP residues 40-53
|
Mutation:T4Y | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;15% PEG4000, 0.1 M MES, 0.15 M ammonium sulfate
|
Resolution 1.43 Å R-free 0.210 |
| 6U7Q NMR solution structure of SFTI-R10 Deposited 2019-09-03 | Different construct Different mutation/modification Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
40–53(14 aa)
|
Mutation:I10R | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 3.5;298 K;Ionic strength (raw mmCIF value) TFA;Pressure Ambient
NMR measurement conditions
pH 3.5;298 K;Ionic strength (raw mmCIF value) TFA;Pressure Ambient
NMR sample composition
1.5 mM SFTI-R10, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 6U7R NMR solution structure of SFTI1 based KLK7 protease inhibitor Deposited 2019-09-03 | Different construct Different mutation/modification Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
40–53(14 aa)
|
Mutation:R2K, T4L, K5N, I7N, D14N | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 3.5;298 K;Ionic strength (raw mmCIF value) TFA;Pressure Ambient
NMR measurement conditions
pH 3.5;298 K;Ionic strength (raw mmCIF value) TFA;Pressure Ambient
NMR sample composition
1.5 mM SFTI-KLK7, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 6U7S NMR solution structure of SFTI-1 based plasmin inhibitor Deposited 2019-09-03 | Different construct Different mutation/modification Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
40–53(14 aa)
|
Mutation:T4Y, I7K | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 3.5;298 K;Ionic strength (raw mmCIF value) TFA;Pressure Ambient
NMR measurement conditions
pH 3.5;298 K;Ionic strength (raw mmCIF value) TFA;Pressure Ambient
NMR sample composition
1.5 mM SFTI-YKK, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
19 other PDB entries and 20 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | SFTI1_HELAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–14; UniProt 1–14 |